Current Limitations and Recent Progress in Nanomedicine for Clinically Available Photodynamic Therapy
Photodynamic therapy (PDT) using oxygen, light, and photosensitizers has been receiving great attention, because it has potential for making up for the weakness of the existing therapies such as surgery, radiation therapy, and chemotherapy. It has been mainly used to treat cancer, and clinical tests...
Main Authors: | Jooho Park, Yong-Kyu Lee, In-Kyu Park, Seung Rim Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/1/85 |
Similar Items
-
Functional Polymer Nanocarriers for Photodynamic Therapy
by: Tuanwei Li, et al.
Published: (2018-11-01) -
A Photosensitizer-Loaded Polydopamine Nanomedicine Agent for Synergistic Photodynamic and Photothermal Therapy
by: Shufeng Yan, et al.
Published: (2023-08-01) -
Cathepsin B-Cleavable Polymeric Photosensitizer Prodrug for Selective Photodynamic Therapy: In Vitro Studies
by: Manish Jain, et al.
Published: (2022-04-01) -
Biocompatible Nanocarriers for Enhanced Cancer Photodynamic Therapy Applications
by: Sathish Sundar Dhilip Kumar, et al.
Published: (2021-11-01) -
Photosensitizers-Loaded Nanocarriers for Enhancement of Photodynamic Therapy in Melanoma Treatment
by: Ana Maria Udrea, et al.
Published: (2023-08-01)